307 related articles for article (PubMed ID: 24855271)
21. Is Disrupted Nucleotide-Substrate Cooperativity a Common Trait for Cushing's Syndrome Driving Mutations of Protein Kinase A?
Walker C; Wang Y; Olivieri C; V S M; Gao J; Bernlohr DA; Calebiro D; Taylor SS; Veglia G
J Mol Biol; 2021 Sep; 433(18):167123. PubMed ID: 34224748
[TBL] [Abstract][Full Text] [Related]
22. Genotype-specific cortisol production associated with Cushing's syndrome adenoma with PRKACA mutations.
Baba R; Oki K; Gomez-Sanchez CE; Otagaki Y; Itcho K; Kobuke K; Kodama T; Nagano G; Ohno H; Yoneda M; Hattori N
Mol Cell Endocrinol; 2021 Dec; 538():111456. PubMed ID: 34520814
[TBL] [Abstract][Full Text] [Related]
23. Genetics of Cushing's syndrome.
Yaneva M; Vandeva S; Zacharieva S; Daly AF; Beckers A
Neuroendocrinology; 2010; 92 Suppl 1():6-10. PubMed ID: 20829611
[TBL] [Abstract][Full Text] [Related]
24. E pluribus unum? The main protein kinase A catalytic subunit (PRKACA), a likely oncogene, and cortisol-producing tumors.
Stratakis CA
J Clin Endocrinol Metab; 2014 Oct; 99(10):3629-33. PubMed ID: 25279575
[No Abstract] [Full Text] [Related]
25. Cushing's syndrome driver mutation disrupts protein kinase A allosteric network, altering both regulation and substrate specificity.
Walker C; Wang Y; Olivieri C; Karamafrooz A; Casby J; Bathon K; Calebiro D; Gao J; Bernlohr DA; Taylor SS; Veglia G
Sci Adv; 2019 Aug; 5(8):eaaw9298. PubMed ID: 31489371
[TBL] [Abstract][Full Text] [Related]
26. Molecular and functional analysis of PRKAR1A and its locus (17q22-24) in sporadic adrenocortical tumors: 17q losses, somatic mutations, and protein kinase A expression and activity.
Bertherat J; Groussin L; Sandrini F; Matyakhina L; Bei T; Stergiopoulos S; Papageorgiou T; Bourdeau I; Kirschner LS; Vincent-Dejean C; Perlemoine K; Gicquel C; Bertagna X; Stratakis CA
Cancer Res; 2003 Sep; 63(17):5308-19. PubMed ID: 14500362
[TBL] [Abstract][Full Text] [Related]
27. Genetic Landscape of Sporadic Unilateral Adrenocortical Adenomas Without PRKACA p.Leu206Arg Mutation.
Ronchi CL; Di Dalmazi G; Faillot S; Sbiera S; Assié G; Weigand I; Calebiro D; Schwarzmayr T; Appenzeller S; Rubin B; Waldmann J; Scaroni C; Bartsch DK; Mantero F; Mannelli M; Kastelan D; Chiodini I; Bertherat J; Reincke M; Strom TM; Fassnacht M; Beuschlein F;
J Clin Endocrinol Metab; 2016 Sep; 101(9):3526-38. PubMed ID: 27389594
[TBL] [Abstract][Full Text] [Related]
28. GNAS mutations in adrenal aldosterone-producing adenomas.
Nakajima Y; Okamura T; Horiguchi K; Gohko T; Miyamoto T; Satoh T; Ozawa A; Ishii S; Yamada E; Hashimoto K; Okada S; Takata D; Horiguchi J; Yamada M
Endocr J; 2016; 63(2):199-204. PubMed ID: 26743443
[TBL] [Abstract][Full Text] [Related]
29. Clinical characteristics of PRKACA mutations in Chinese patients with adrenal lesions: a single-centre study.
Li X; Wang B; Tang L; Lang B; Zhang Y; Zhang F; Chen L; Ouyang J; Zhang X
Clin Endocrinol (Oxf); 2016 Dec; 85(6):954-961. PubMed ID: 27296931
[TBL] [Abstract][Full Text] [Related]
30. Somatic PRKACA Mutations: Association With Transition From Pituitary-Dependent to Adrenal-Dependent Cushing Syndrome.
Di Dalmazi G; Timmers HJLM; Arnaldi G; Küsters B; Scarpelli M; Bathon K; Calebiro D; Beuschlein F; Hermus A; Reincke M
J Clin Endocrinol Metab; 2019 Nov; 104(11):5651-5657. PubMed ID: 31276155
[TBL] [Abstract][Full Text] [Related]
31. ACTH-independent Cushing's syndrome with bilateral micronodular adrenal hyperplasia and ectopic adrenocortical adenoma.
Louiset E; Gobet F; Libé R; Horvath A; Renouf S; Cariou J; Rothenbuhler A; Bertherat J; Clauser E; Grise P; Stratakis CA; Kuhn JM; Lefebvre H
J Clin Endocrinol Metab; 2010 Jan; 95(1):18-24. PubMed ID: 19915020
[TBL] [Abstract][Full Text] [Related]
32. Genetics: Pinpointing a hotspot in adrenal Cushing syndrome.
Giordano TJ
Nat Rev Endocrinol; 2014 Aug; 10(8):447-8. PubMed ID: 24913521
[No Abstract] [Full Text] [Related]
33. Protein kinase A alterations in adrenocortical tumors.
Espiard S; Ragazzon B; Bertherat J
Horm Metab Res; 2014 Nov; 46(12):869-75. PubMed ID: 25105543
[TBL] [Abstract][Full Text] [Related]
34. Steroidogenic Acute Regulatory Protein Overexpression Correlates with Protein Kinase A Activation in Adrenocortical Adenoma.
Zhou W; Wu L; Xie J; Su T; Jiang L; Jiang Y; Cao Y; Liu J; Ning G; Wang W
PLoS One; 2016; 11(9):e0162606. PubMed ID: 27606678
[TBL] [Abstract][Full Text] [Related]
35. Carney complex: an update.
Correa R; Salpea P; Stratakis CA
Eur J Endocrinol; 2015 Oct; 173(4):M85-97. PubMed ID: 26130139
[TBL] [Abstract][Full Text] [Related]
36. The genetics of adrenocortical tumors.
Espiard S; Bertherat J
Endocrinol Metab Clin North Am; 2015 Jun; 44(2):311-34. PubMed ID: 26038203
[TBL] [Abstract][Full Text] [Related]
37. [New insights in adrenal Cushing syndrome].
Haissaguerre M; Tabarin A
Ann Endocrinol (Paris); 2014 Oct; 75 Suppl 1():S37-45. PubMed ID: 25617921
[TBL] [Abstract][Full Text] [Related]
38. Clinical and Molecular Characteristics of PRKACA L206R Mutant Cortisol-Producing Adenomas in Korean Patients.
Jang I; Kim SJ; Song RY; Kim K; Choi S; Lee JS; Gwon MK; Seong MW; Lee KE; Kim JH
Endocrinol Metab (Seoul); 2021 Dec; 36(6):1287-1297. PubMed ID: 34852451
[TBL] [Abstract][Full Text] [Related]
39. Cushing's syndrome and fetal features resurgence in adrenal cortex-specific Prkar1a knockout mice.
Sahut-Barnola I; de Joussineau C; Val P; Lambert-Langlais S; Damon C; Lefrançois-Martinez AM; Pointud JC; Marceau G; Sapin V; Tissier F; Ragazzon B; Bertherat J; Kirschner LS; Stratakis CA; Martinez A
PLoS Genet; 2010 Jun; 6(6):e1000980. PubMed ID: 20548949
[TBL] [Abstract][Full Text] [Related]
40. Abnormalities of cAMP signaling are present in adrenocortical lesions associated with ACTH-independent Cushing syndrome despite the absence of mutations in known genes.
Bimpaki EI; Nesterova M; Stratakis CA
Eur J Endocrinol; 2009 Jul; 161(1):153-61. PubMed ID: 19429701
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
